Florilglutamic acid F-18 Completed Phase 2 Trials for Stage IV Breast Cancer / Progesterone Receptor Negative / B-Cell Neoplasm / Stage IIIA Breast Cancer / Stage III Renal Cell Cancer / Triple-Negative Breast Carcinoma / Metastatic Renal Cell Cancer / Stage IIIb Non-small Cell Lung Cancer / Estrogen Receptor Negative / Stage IV Renal Cell Cancer / Stage IV Non-Small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIC Breast Cancer / Stage IV Mesothelioma / Stage III Mesothelioma / HER2/Neu Negative Diagnostic